Management of rheumatoid arthritis.
Identifieur interne : 003436 ( Main/Merge ); précédent : 003435; suivant : 003437Management of rheumatoid arthritis.
Auteurs : C E Dugowson ; B C GillilandSource :
- Disease-a-month : DM [ 0011-5029 ] ; 1986.
Descripteurs français
- KwdFr :
- Anti-inflammatoires (effets indésirables), Anti-inflammatoires (usage thérapeutique), Arthrite juvénile (physiopathologie), Association de médicaments, Azathioprine (usage thérapeutique), Chloroquine (usage thérapeutique), Cyclophosphamide (usage thérapeutique), Humains, Hydroxychloroquine (usage thérapeutique), Immunosuppresseurs (usage thérapeutique), Leucaphérèse, Maladies du rachis (), Maladies pulmonaires (), Méthotrexate (usage thérapeutique), Or (usage thérapeutique), Plasmaphérèse, Polyarthrite rhumatoïde (), Polyarthrite rhumatoïde (anatomopathologie), Polyarthrite rhumatoïde (étiologie), Pénicillamine (usage thérapeutique), Radiothérapie, Rhumatismes (traitement médicamenteux), Salicylates (usage thérapeutique), Syndrome de Felty (traitement médicamenteux), Syndrome de Gougerot-Sjögren (traitement médicamenteux), Tissu lymphoïde (effets des radiations), Vascularite (traitement médicamenteux).
- MESH :
- anatomopathologie : Polyarthrite rhumatoïde.
- effets des radiations : Tissu lymphoïde.
- effets indésirables : Anti-inflammatoires.
- physiopathologie : Arthrite juvénile.
- traitement médicamenteux : Rhumatismes, Syndrome de Felty, Syndrome de Gougerot-Sjögren, Vascularite.
- usage thérapeutique : Anti-inflammatoires, Azathioprine, Chloroquine, Cyclophosphamide, Hydroxychloroquine, Immunosuppresseurs, Méthotrexate, Or, Pénicillamine, Salicylates.
- étiologie : Polyarthrite rhumatoïde.
- Association de médicaments, Humains, Leucaphérèse, Maladies du rachis, Maladies pulmonaires, Plasmaphérèse, Polyarthrite rhumatoïde, Radiothérapie.
English descriptors
- KwdEn :
- Anti-Inflammatory Agents (adverse effects), Anti-Inflammatory Agents (therapeutic use), Arthritis, Juvenile (physiopathology), Arthritis, Rheumatoid (complications), Arthritis, Rheumatoid (etiology), Arthritis, Rheumatoid (pathology), Arthritis, Rheumatoid (therapy), Azathioprine (therapeutic use), Chloroquine (therapeutic use), Cyclophosphamide (therapeutic use), Drug Therapy, Combination, Felty Syndrome (drug therapy), Gold (therapeutic use), Humans, Hydroxychloroquine (therapeutic use), Immunosuppressive Agents (therapeutic use), Leukapheresis, Lung Diseases (complications), Lymphoid Tissue (radiation effects), Methotrexate (therapeutic use), Penicillamine (therapeutic use), Plasmapheresis, Radiotherapy, Rheumatic Diseases (drug therapy), Salicylates (therapeutic use), Sjogren's Syndrome (drug therapy), Spinal Diseases (complications), Vasculitis (drug therapy).
- MESH :
- chemical , adverse effects : Anti-Inflammatory Agents.
- chemical , therapeutic use : Anti-Inflammatory Agents, Azathioprine, Chloroquine, Cyclophosphamide, Gold, Hydroxychloroquine, Immunosuppressive Agents, Methotrexate, Penicillamine, Salicylates.
- complications : Arthritis, Rheumatoid, Lung Diseases, Spinal Diseases.
- drug therapy : Felty Syndrome, Rheumatic Diseases, Sjogren's Syndrome, Vasculitis.
- etiology : Arthritis, Rheumatoid.
- pathology : Arthritis, Rheumatoid.
- physiopathology : Arthritis, Juvenile.
- radiation effects : Lymphoid Tissue.
- therapy : Arthritis, Rheumatoid.
- Drug Therapy, Combination, Humans, Leukapheresis, Plasmapheresis, Radiotherapy.
DOI: 10.1016/s0011-5029(86)80002-5
PubMed: 3512214
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000587
- to stream PubMed, to step Curation: 000587
- to stream PubMed, to step Checkpoint: 000557
- to stream Ncbi, to step Merge: 001055
- to stream Ncbi, to step Curation: 001055
- to stream Ncbi, to step Checkpoint: 001055
Links to Exploration step
pubmed:3512214Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of rheumatoid arthritis.</title><author><name sortKey="Dugowson, C E" sort="Dugowson, C E" uniqKey="Dugowson C" first="C E" last="Dugowson">C E Dugowson</name></author><author><name sortKey="Gilliland, B C" sort="Gilliland, B C" uniqKey="Gilliland B" first="B C" last="Gilliland">B C Gilliland</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1986">1986</date><idno type="RBID">pubmed:3512214</idno><idno type="pmid">3512214</idno><idno type="doi">10.1016/s0011-5029(86)80002-5</idno><idno type="wicri:Area/PubMed/Corpus">000587</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000587</idno><idno type="wicri:Area/PubMed/Curation">000587</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000587</idno><idno type="wicri:Area/PubMed/Checkpoint">000557</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000557</idno><idno type="wicri:Area/Ncbi/Merge">001055</idno><idno type="wicri:Area/Ncbi/Curation">001055</idno><idno type="wicri:Area/Ncbi/Checkpoint">001055</idno><idno type="wicri:doubleKey">0011-5029:1986:Dugowson C:management:of:rheumatoid</idno><idno type="wicri:Area/Main/Merge">003436</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Management of rheumatoid arthritis.</title><author><name sortKey="Dugowson, C E" sort="Dugowson, C E" uniqKey="Dugowson C" first="C E" last="Dugowson">C E Dugowson</name></author><author><name sortKey="Gilliland, B C" sort="Gilliland, B C" uniqKey="Gilliland B" first="B C" last="Gilliland">B C Gilliland</name></author></analytic><series><title level="j">Disease-a-month : DM</title><idno type="ISSN">0011-5029</idno><imprint><date when="1986" type="published">1986</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Inflammatory Agents (adverse effects)</term><term>Anti-Inflammatory Agents (therapeutic use)</term><term>Arthritis, Juvenile (physiopathology)</term><term>Arthritis, Rheumatoid (complications)</term><term>Arthritis, Rheumatoid (etiology)</term><term>Arthritis, Rheumatoid (pathology)</term><term>Arthritis, Rheumatoid (therapy)</term><term>Azathioprine (therapeutic use)</term><term>Chloroquine (therapeutic use)</term><term>Cyclophosphamide (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Felty Syndrome (drug therapy)</term><term>Gold (therapeutic use)</term><term>Humans</term><term>Hydroxychloroquine (therapeutic use)</term><term>Immunosuppressive Agents (therapeutic use)</term><term>Leukapheresis</term><term>Lung Diseases (complications)</term><term>Lymphoid Tissue (radiation effects)</term><term>Methotrexate (therapeutic use)</term><term>Penicillamine (therapeutic use)</term><term>Plasmapheresis</term><term>Radiotherapy</term><term>Rheumatic Diseases (drug therapy)</term><term>Salicylates (therapeutic use)</term><term>Sjogren's Syndrome (drug therapy)</term><term>Spinal Diseases (complications)</term><term>Vasculitis (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anti-inflammatoires (effets indésirables)</term><term>Anti-inflammatoires (usage thérapeutique)</term><term>Arthrite juvénile (physiopathologie)</term><term>Association de médicaments</term><term>Azathioprine (usage thérapeutique)</term><term>Chloroquine (usage thérapeutique)</term><term>Cyclophosphamide (usage thérapeutique)</term><term>Humains</term><term>Hydroxychloroquine (usage thérapeutique)</term><term>Immunosuppresseurs (usage thérapeutique)</term><term>Leucaphérèse</term><term>Maladies du rachis ()</term><term>Maladies pulmonaires ()</term><term>Méthotrexate (usage thérapeutique)</term><term>Or (usage thérapeutique)</term><term>Plasmaphérèse</term><term>Polyarthrite rhumatoïde ()</term><term>Polyarthrite rhumatoïde (anatomopathologie)</term><term>Polyarthrite rhumatoïde (étiologie)</term><term>Pénicillamine (usage thérapeutique)</term><term>Radiothérapie</term><term>Rhumatismes (traitement médicamenteux)</term><term>Salicylates (usage thérapeutique)</term><term>Syndrome de Felty (traitement médicamenteux)</term><term>Syndrome de Gougerot-Sjögren (traitement médicamenteux)</term><term>Tissu lymphoïde (effets des radiations)</term><term>Vascularite (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Inflammatory Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term><term>Azathioprine</term><term>Chloroquine</term><term>Cyclophosphamide</term><term>Gold</term><term>Hydroxychloroquine</term><term>Immunosuppressive Agents</term><term>Methotrexate</term><term>Penicillamine</term><term>Salicylates</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Arthritis, Rheumatoid</term><term>Lung Diseases</term><term>Spinal Diseases</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Felty Syndrome</term><term>Rheumatic Diseases</term><term>Sjogren's Syndrome</term><term>Vasculitis</term></keywords><keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Tissu lymphoïde</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anti-inflammatoires</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Arthrite juvénile</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arthritis, Juvenile</term></keywords><keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Lymphoid Tissue</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Rhumatismes</term><term>Syndrome de Felty</term><term>Syndrome de Gougerot-Sjögren</term><term>Vascularite</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term><term>Azathioprine</term><term>Chloroquine</term><term>Cyclophosphamide</term><term>Hydroxychloroquine</term><term>Immunosuppresseurs</term><term>Méthotrexate</term><term>Or</term><term>Pénicillamine</term><term>Salicylates</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term><term>Humans</term><term>Leukapheresis</term><term>Plasmapheresis</term><term>Radiotherapy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Humains</term><term>Leucaphérèse</term><term>Maladies du rachis</term><term>Maladies pulmonaires</term><term>Plasmaphérèse</term><term>Polyarthrite rhumatoïde</term><term>Radiothérapie</term></keywords></textClass></profileDesc></teiHeader></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003436 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003436 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:3512214
|texte= Management of rheumatoid arthritis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:3512214" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |